Best Stocks to Buy Now in May 2026, According to Analysts
Reviewed by: David Bernstein, CFA, Head of Quantitative Research Last Updated & Reviewed: May 15, 2026
If you left your investment portfolio on autopilot at the start of the year, your brokerage account is likely sending you mixed signals. The stock market is acting like a divided highway. On one side, high-flying artificial intelligence juggernauts are moving fast, fueled by relentless corporate spending. On the other side, legacy consumer defensive giants are quietly staging massive comebacks as value investors look for a safety net against sticky inflation.
Trying to navigate this environment alone is a fast track to underperformance. What worked during the tech bull runs of previous years is being heavily re-evaluated. Wall Street institutions are shifting their capital into a distinct blend of hyper-growth technology infrastructure and highly discounted, cash-generating dividend stocks.
We sifted through hundreds of Q1 2026 corporate earnings reports, calculated price-to-fair-value ratios, and analyzed institutional consensus ratings to isolate the absolute best stocks to buy now in May 2026, according to analysts.
Real Investors, Real Portfolios: Navigating May 2026’s Market Realities
To understand why a random mix of popular stocks will no longer cut it, let’s look at how three distinct, real-world investors are managing their capital this month:
* Scenario A (The Portfolio Rebalancer): James is a 45-year-old IT manager whose portfolio became dangerously top-heavy with technology shares over the last two years. He doesn’t want to abandon tech completely, but he urgently needs to reallocate some of his profits into highly stable, wide-moat companies that offer downside protection and reliable passive income.
* Scenario B (The Aggressive Growth Chaser): Priya is a 28-year-old software engineer who is looking for maximum capital appreciation. She isn’t interested in safe, slow-moving retail stocks; she wants direct exposure to companies whose underlying infrastructure is receiving hundreds of billions of dollars in enterprise spending right now.
* Scenario C (The Deep-Value Hunter): Robert is a retired accountant who refuses to buy overvalued, high-multiple tech names. He is actively hunting for high-quality, undervalued dividend aristocrats trading at a steep discount to their intrinsic fair value, allowing him to lock in historically high forward dividend yields.
The Growth Heavyweights: Best Stocks to Buy Now in May 2026, According to Analysts
If your investment goal aligns with Priya’s aggressive growth trajectory, Wall Street’s top analysts are screaming from the rooftops about two infrastructure titans that are dominating institutional buy lists this month.
* Amazon (AMZN) Amazon’s freshly released Q1 2026 financial results have forced major Wall Street firms to aggressively adjust their price targets upward. The core catalyst isn’t just retail delivery—it’s the explosive re-acceleration of Amazon Web Services (AWS).
Enterprise workloads are migrating to the cloud at a rapid pace, and Amazon’s proprietary AI silicon and cloud chip business is now running at a staggering $20 billion annualized rate. Analysts point out that as companies scale their generative AI applications, they are forced to expand their foundational cloud infrastructure with AWS. This makes Amazon one of the safest, most cash-rich methods to play the ongoing enterprise AI boom without paying the speculative multiples found elsewhere in the tech sector.
* NVIDIA (NVDA) It is easy to assume that the ship has already sailed on NVIDIA, but Wall Street’s institutional consensus says otherwise. NVIDIA remains the undisputed bedrock of the global artificial intelligence infrastructure. Every major tech company—from Meta and Microsoft to Alphabet and Amazon—is pouring billions into data centers, and those data centers require NVIDIA’s advanced graphic processing units (GPUs).
While retail day traders panic over short-term profit-taking dips, institutional analysts view these pullbacks as textbook buying opportunities. The structural demand for AI training and real-time model inference shows no signs of slowing down, cementing NVDA’s position near the top of the list for high-conviction growth.
The Value and Income Plays: Locking in Massive Discounts
For investors like James and Robert who prefer structural safety and rich cash flows, Morningstar’s latest equity research highlights an incredible disconnect in the consumer defensive and healthcare sectors. Several elite businesses are trading at massive discounts compared to their underlying intrinsic value.
* Clorox (CLX) Clorox currently sits at the absolute top of many analyst lists for undervalued dividend aristocrats. Equity strategists note that Clorox stock is trading at a steep 45% discount to its estimated fair value of $163 per share. Boasting a wide economic moat and a forward dividend yield hovering around 5.51%, the company is a cash-generating fortress.
Wall Street analysts project steady mid-single-digit dividend growth over the next decade, making it a stellar defensive anchor for any portfolio looking to weather broader macroeconomic volatility.
* Medtronic (MDT) In the healthcare sector, medical device manufacturer Medtronic is flashing a clear buy signal. Analysts point out that Medtronic is trading roughly 34% below its long-term fair value estimate of $112.
The firm has a long-standing corporate mandate of distributing at least 50% of its free cash flow back to shareholders, though its payout ratio has crept up closer to 70% to 80% recently. With a narrow economic moat and a resilient product pipeline protecting it from generic competition, Medtronic offers a highly attractive 3.85% forward dividend yield at a heavily discounted entry price.
Portfolio Strategy: How to Balance Growth and Value This Month
To successfully deploy capital into the best stocks to buy now in May 2026, according to analysts, you must avoid the trap of going entirely into one sector. A balanced portfolio allocation model is essential for long-term outperformance.
Instead of chasing singular trends, institutional strategists recommend a barbell strategy. On one end of the barbell, allocate capital to high-margin, cash-flush technology giants like Amazon that possess clear, structural secular tailwinds. On the other end, balance that risk by accumulating shares of deeply discounted value plays like Clorox or Medtronic.
This approach ensures you remain fully invested in the market’s primary growth engines while protecting your downside via high-yielding, wide-moat businesses that pay you to wait.
Frequently Asked Questions
1. Why are analysts favoring Amazon over other mega-cap tech stocks right now? Wall Street analysts are heavily favoring Amazon because of the massive profit margins driven by AWS and its rapidly expanding digital advertising ecosystem. Unlike pure-play hardware tech firms that are vulnerable to supply chain issues, Amazon’s cloud architecture is experiencing direct, compounding revenue gains from the enterprise artificial intelligence boom.
2. Is NVIDIA still a safe buy at its current valuation? While NVIDIA carries a premium valuation multiple, analysts argue it is entirely justified by its near-monopoly on high-end AI chips. Institutional researchers note that as long as big tech capital expenditures on data centers continue to grow, NVIDIA’s earnings will keep expanding to support its stock price.
3. What makes a stock a true “Dividend Aristocrat”? A Dividend Aristocrat is an elite company within the S&P 500 index that has successfully increased its base dividend payout to shareholders for at least 25 consecutive years. These stocks are highly prized by analysts during periods of economic uncertainty because their histories prove they possess incredibly resilient business models and highly dependable cash flows.
4. How do rising interest rates affect the best stocks to buy now in May 2026, according to analysts? Persistent interest rates cause analysts to heavily favor companies with clean balance sheets, low debt-to-equity ratios, and massive cash positions. High-growth companies with poor cash flow are penalized by Wall Street, while capital-rich giants like Amazon and wide-moat dividend paying stalwarts like Clorox tend to dramatically outperform.
5. Why is Clorox trading at such a significant discount to its fair value? Clorox’s stock price has faced temporary downward pressure due to short-term input cost inflation and the lingering normalization of consumer habits. However, Wall Street analysts view this sell-off as an overreaction, pointing out that the company’s brand loyalty and pricing power ensure its long-term profitability remains completely intact.
6. Should I buy individual stocks or stick to an index fund like the S&P 500? If you want to mirror the general market’s returns with minimal effort, an index fund is highly efficient. However, analysts point out that broad indexes are heavily weighted by a few massive companies; choosing specific, deeply undervalued individual stocks allows investors to actively beat the market by avoiding overvalued sectors.
7. How often should I rebalance my stock portfolio? Most financial advisors and Wall Street strategists recommend reviewing and rebalancing your portfolio either quarterly or semi-annually. This schedule keeps your asset allocation aligned with your risk tolerance and prevents a single booming stock or sector from making your portfolio top-heavy.
8. What is an economic moat and why do analysts care about it? Coined by Warren Buffett, an economic moat refers to a company’s distinct, sustainable competitive advantage that protects it from rivals. Analysts prioritize wide-moat companies—like Clorox or Medtronic—because their patents, brand power, or regulatory advantages make it nearly impossible for new competitors to steal their market share.
The Final Takeaway
Successful investing requires tuning out daily market noise and focusing entirely on structural business fundamentals. The data from May 2026 clearly shows that the most profitable move you can make right now is embracing a balanced portfolio. By anchoring your capital in deeply discounted, high-yield dividend aristocrats while maintaining calculated exposure to elite tech infrastructure giants, you position yourself to capture major market upside while remaining completely insulated from sudden macroeconomic shifts.
U.S. Securities and Exchange Commission (SEC): Corporate Q1 2026 Form 10-Q Filings and Financial Disclosures Morningstar Equity Research: Comprehensive Moat Ratings, Dividend Aristocrat Indexes, and Fair Value Valuations The Zacks Research Wizard: Institutional Consensus Ratings, Earnings Per Share (EPS) Growth Forecasts, and Strong Buy Screeners
